BICX logo

BioCorRx Inc. Stock Price

OTCPK:BICX Community·US$8.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BICX Share Price Performance

US$0.45
0.09 (24.44%)
US$0.45
0.09 (24.44%)
Price US$0.45

BICX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Medium-low risk with limited growth.

7 Risks
1 Reward

BioCorRx Inc. Key Details

US$313.1k

Revenue

US$0

Cost of Revenue

US$313.1k

Gross Profit

US$5.0m

Other Expenses

-US$4.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.23
100.00%
-1,509.51%
-21.2%
View Full Analysis

About BICX

Founded
2009
Employees
n/a
CEO
Lourdes Felix
WebsiteView website
www.biocorrx.com

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of alcohol and opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.

Recent BICX News & Updates

Recent updates

No updates